
Presbyopia CSF-1 drops’ trial success
Phase 2b trials of Orasis Pharmaceuticals’ presbyopia treatment, CSF-1 (0.4% pilocarpine HCl) showed 80% patients achieved a two-line improvement in near vision, comparable to achieving 20/40 or

Phase 2b trials of Orasis Pharmaceuticals’ presbyopia treatment, CSF-1 (0.4% pilocarpine HCl) showed 80% patients achieved a two-line improvement in near vision, comparable to achieving 20/40 or

Aiming to establish a trans-Tasman network to collaboratively devise new strategies to benefit patients and the eye health sector, Specsavers held its first cross-sector meeting for patient support bodies from Australia and New Zealand.

Hoya Vision Care has launched a Miyosmart sun range of photochromic or polarised lenses to provide sun protection while slowing myopia progression in children. Miyosmart Chameleon (photochromic) and

The Australian Health Practitioner Regulation Agency (Ahpra) is calling for feedback from medical professionals as it reviews the national standard that sets the bar for criminal history for its

US researchers found an anti-IL-6 antibody optimised for intravitreal injection (RG6179, Roche) resulted in improved vision and retinal thickness and was well tolerated in uveitic macular oedema (UMO)

US researchers have demonstrated retinal vessel skeleton density (VSD) showed significant association with at least some measures of cognition, even in cognitively intact subjects at risk of vascular

A Macquarie University team has discovered that damaging a key protein can weaken Acinetobacter baumannii – an antibiotic-resistant bacterium able to survive for a year on dry hospital

Melbourne-based muPharma has developed an ultrasound-based, non-invasive device to deliver drugs which would ordinarily require injection or other highly invasive delivery methods. The device’s

Melbourne-based muPharma has developed an ultrasound-based, non-invasive device to deliver drugs which would ordinarily require injection or other highly invasive delivery methods. The device’s

Alcon’s new global cataract survey has revealed less than half of Australians surveyed understand cataract surgery involves implanting a new permanent lens.

The recent letter from the Royal Australian and New Zealand College of Ophthalmologists (RANZCO), urging its New Zealand members not to train experienced hospital optometrists to do minor laser

Approximately 3,500 more cataract surgeries will be delivered in New Zealand over the next 18 months, following the government’s implementation of a nationally consistent Clinical Priority Assessment
